The approval which was based on positive results from the global single-arm ARROS-1 Phase 1/2 trial provides a quick return on GSKs investment and validates the decision to step into the oncology space
To be honest, I cant watch it
While the exact reasons arent clear, researchers point to things like body weight, side effect sensitivity, and hormonal factors
They were patients on Ozempic and Wegovy, prescribed the drugs for diabetes or weight loss, who mentioned to their doctors that something odd had happened to their relationship with alcohol: the second glass of wine had stopped calling, the after-work beer had lost its pull, the craving had simply gone quiet
ConclusionBPC-157 is ahealing peptidewith powerful regenerative and protective properties, particularly useful in treatinginjuriesandgastrointestinal disorders